Measurement of disease activity in ulcerative colitis: Interobserver agreement and predictors of severity

Inflammatory Bowel Diseases

Volumn 17, Issue 6, 2011, Pages 1257-1264

  Thia, Kelvin T ^a,b   Loftus Jr , Edward V ^a   Pardi, Darrell S ^a   Kane, Sunanda V ^a   Faubion, William A ^a   Tremaine, William J ^a   Schroeder, Kenneth W ^a   Harmsen, Scott W ^a   Zinsmeister, Alan R ^a   Sandborn, William J ^a  

^a MAYO CLINIC   (United States)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

diagnosis; disease activity; endoscopic evaluation; ulcerative colitis

Indexed keywords

ADULT; AGED; ARTICLE; ASCENDING COLON; CECUM; COLON MUCOSA; COLON ULCER; COLONOSCOPY; DESCENDING COLON; DISEASE ACTIVITY; DISEASE SEVERITY; EDEMA; ENTERITIS; ERYTHEMA; FEMALE; HUMAN; INTESTINE INJURY; INTESTINE OBSTRUCTION; INTESTINE POLYP; LARGE INTESTINE HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECTUM; SIGMOID; TRANSVERSE COLON; ULCERATIVE COLITIS; VASCULARIZATION; VIDEORECORDING; VISUAL ANALOG SCALE; WOUND HEALING;

ADULT; AGED; COLITIS, ULCERATIVE; COLON; COLONOSCOPY; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; OBSERVER VARIATION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VIDEO RECORDING; YOUNG ADULT;

EID: 79955796048     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21480     Document Type: Article

References (14)

1. Baron JH, Connell AM, Lennard-Jones JE,. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J. 1964; 1: 89-92.
2. de Lange T, Larsen S, Aabakken L,. Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis. BMC Gastroenterol. 2004; 4: 9.
3. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007; 132: 763-786.
4. Orlandi F, Brunelli E, Feliciangeli G, et al. Observer agreement in endoscopic assessment of ulcerative colitis. Ital J Gastroenterol Hepatol. 1998; 30: 539-541. (Pubitemid 28517811)
5. Rutgeerts P, Colombel JF, Reinisch W, et al. Infliximab induces and maintains mucosal healing in patients with active ulcerative colitis: the ACT trial experience. Gut. 2005; 54 (suppl VII): A8.
6. Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007; 133: 412-422. (Pubitemid 47187355)
7. Rutgeerts P, Vermeire S, Van Assche G,. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut. 2007; 56: 453-455. (Pubitemid 46580492)
8. Feagan BG, Greenberg GR, Wild G, et al. Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin. N Engl J Med. 2005; 352: 2499-2507. (Pubitemid 41007865)
9. Schroeder KW, Tremaine WJ, Ilstrup DM., Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987; 317: 1625-1629. (Pubitemid 18010466)
10. Carrasco JL, Jover L., Estimating the generalized concordance correlation coefficient through variance components. Biometrics 2003; 59: 849-858. (Pubitemid 38021213)
11. Walsh AJ, Brain O, Keshav S, et al. How variable is the Mayo score between observers and might this affect trial recruitment or outcome? Gastroenterology. 2009; 136 (suppl 1): A677.
12. Levine DS, Riff DS, Pruitt R, et al. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis. Am J Gastroenterol. 2002; 97: 1398-1407. (Pubitemid 34664784)
13. Maunder RG, Greenberg GR,. Comparison of a disease activity index and patients' self-reported symptom severity in ulcerative colitis. Inflamm Bowel Dis. 2004; 10: 632-636. (Pubitemid 39276473)
14. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007; 133: 423-432. (Pubitemid 47193130)